Protein C is a normal substance in the body that prevents blood clotting. A blood test can be done to see how much of this protein you have in your blood.
Autoprothrombin IIA
A blood sample is needed.
Certain medicines can change blood test results.
When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or slight bruising. This soon goes away.
You may need this test if you have an unexplained blood clot or a family history of blood clots. Protein C helps control blood clotting. A lack of this protein or a problem with the function of this protein may cause blood clots to form in veins abnormally.
The test is also used to screen relatives of people who are known to have protein C deficiency. It may also be done to find the reason for repeated miscarriages.
Normal values are 60% to 150% inhibition.
Normal value ranges may vary slightly among different laboratories. Some labs use different measurements or may test different samples. Talk to your provider about the meaning of your specific test results.
A lack (deficiency) of protein C can lead to excess clotting. These clots tend to form in veins, not arteries.
Protein C deficiency can be passed down through families (inherited). It can also develop with other conditions, such as:
A problem such as a sudden blood clot in the lung may reduce the protein C level.
Protein C level rises with age or while pregnant, but this does not cause any health problems.
There is little risk involved with having your blood taken. Veins and arteries vary in size from one person to another, and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
Other risks associated with having blood drawn are slight, but may include:
Anderson JA, Weitz JI. Hypercoagulable states. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 138.
Review Date:
2/2/2023 Reviewed By: Mark Levin, MD, Hematologist and Oncologist, Monsey, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. |